The future of medicine is based on intensive research. Innovations from genetic research and digitization, for example, are revolutionizing medicine and healthcare more than ever before. Strong entrepreneurs are also needed to turn scientists’ results into real products and help to improve patients’ diagnosis, prevention, therapy, nursing and rehabilitation. These stories provide insights into the top research and development in central Hessen and show the latest trends – always for the benefit of patients all over the world.
Lack of orders, lack of network, a shortage of money: There are many reasons why startups go bankrupt. To prevent this, the Technology and Innovation Center Giessen (TIG) offers young companies support programs, internal networking and affordable commercial space – and all of this in the economic stronghold of Central Hessen.
One litre of blood plasma can be used in 17 different product lines against rare diseases: The Marburg-based biotechnology company CSL Behring uses the plasma to produce drugs for the treatment of hereditary angioedema (HAE) and haemophilia.
Dr. Nadine Biedenkopf, a scientist from Marburg, is researching substances against dangerous viruses such as Ebola. Silvestrol gives hope.
Researchers in Central Hessen, Germany, are taking up the fight against Antibiotic resistance, including a search for new ways to combat infectious diseases.
More and more people are affected by neglected tropical diseases (NTDs). As a result, many countries now recognize the importance of fighting NTDs. The German’s federal state Hessen is also making its contribution. Find out how NTDs are fought in the LOEWE Centre DRUID.
Small beetles are more productive than you think: They can heal wounds or provide basic substances for the production of antibiotics. That’s why scientists at the Fraunhofer Institute in Giessen, Germany, are researching how these crawling insects can be used in medicine – and how they are already successful.
Ventilators are not always life-savers: Although sending oxygen to the lungs is fundamental during operations, the body’s movements during breathing – such as the rise and fall of the chest – can actually interfere with receiving oxygen. A new revolutionary ventilation technology from Central Hessen, Germany, is able to avert this danger.
Patients with pulmonary hypertension live with constant shortness of breath. Currently, this disease is not curable; patient symptoms can only be alleviated. But a team of researchers in Giessen, Germany, examined Fucoidan, a brown algae extract, for pulmonary hypertension treatment, and they have come to promising results.